Ischemia-reperfusion injury is an important cause of liver damage occurring during surgical procedures including hepatic resection and liver transplantation, and represents the main underlying cause of graft dysfunction post-transplantation. Cellular and biochemical processes occurring during hepatic ischemia-reperfusion are diverse and complex, and include the deregulation of the healthy phenotype of all liver cellular components. Nevertheless, a significant part of these processes are still unknown or unclear. The present review aims at summarizing the current knowledge in liver ischemia-reperfusion, but specifically focusing on liver cell phenotype and paracrine interaction deregulations. Moreover, the most updated therapeutic strategies including pharmacological, genetic and surgical interventions, as well as some of the scientific controversies in the field will be described. Finally, the importance of considering the subclinical situation of liver grafts when translating basic knowledge to the bedside is discussed. Ó 2013 European Association for the Study of the Liver. Published by Elsevier B.V.
LSEC are particularly vulnerable to I/R injury and develop serious alterations during cold storage (Fig. 2 ). In fact, pioneering studies by Caldwell-Kenkel and colleagues described the deregulation of LSEC viability due to I/R injury as plasma membranes discontinuation, nuclear membranes vacuolization, and cell shape rounding [9] . These very initial observations, which were usually reported at the Kupffer Cell Foundation meetings (currently the International Society for Hepatic Sinusoidal Research), have been extended during the last decades. Nowadays, it is accepted that hepatic endothelium damage occurring during cold preservation represents the initial factor leading to hepatic I/R injury, determining poor graft microcirculation, platelet activation, persistent vasoconstriction, upregulation of adhesion molecules, oxidative stress, Kupffer cell activation, neutrophil infiltration, and hepatocyte death.
During the ischemic period, the lack of energetic substrate interferes with active transmembrane transport, producing edema in KC and LSEC [10] . This fact, together with the imbalance between low nitric oxide (NO) bioavailability and exacerbated endothelin (ET) and thromboxane A2 (TXA 2 ) production, contributes to narrowing the sinusoidal lumen, and thus to microcirculatory dysfunction. Diminished NO levels within the liver during I/R are derived from both decreased production and increased scavenging by elevated levels of ROS, and ultimately modulate the intensity of the I/R injury by regulating neutrophil adhesion, platelet aggregation, and HSC contraction [11] [12] [13] . In addition, recent studies have demonstrated that lack of biomechanical stimuli occurring during cold preservation for transplantation markedly deteriorates LSEC protective phenotype by downregulating the expression of the transcription factor Kruppel-like Factor 2 (KLF2), which orchestrates the transcription of a variety of protective genes including the endothelial synthase of NO (eNOS), the anti-thrombotic molecule thrombomodulin, or the antioxidant transcription factor Nrf2 [4, 14] .
Concomitantly to LSEC deregulation, KC suffer from a profound activation process that is promoted by neighbour hepatic cellsreleased damage-associated molecular patterns (DAMPs) and, under conditions of sepsis or endotoxemia, also by pathogen-associated molecular patterns (PAMPs) [15, 16] . Activated KC significantly increase their release of ROS and pro-inflammatory cytokines, including tumour necrosis factor-a (TNF-a), interleukin-1 (IL-1), interferon-c (INF-c) and interleukin-12 (IL-12) ( Fig. 2) [17, 18] . Both TNF-a and IL-1 upregulate Mac-1 (CD11b/CD18) adhesion proteins on neutrophils and induce IL-8 synthesis, further promoting neutrophil chemotaxis within the parenchyma [19] . Moreover, IL-1 has the potential to stimulate the release of ROS by neutrophils, which will further increase TNF-a synthesis by KC [20] . TNF-a stimulates the expression of the intracellular adhesion molecule-1 (ICAM-1) on the intraluminal side of LSEC, contributing to neutrophil rolling, binding, and parenchymal extravasation [20] . TNF-a also induces P-selectin expression in LSEC, being essential for the recruitment of neutrophils [21] . TNF-a has been shown to increase the release of other molecules, including interleukin-6 (IL-6), macrophage inflammatory protein-2 (MIP-2), epithelial neutrophil activating protein-78 (ENA-78), cytokine-induced neutrophil chemoattractant-1 (CINC), and a number of CXC motif chemokines (including CXL-1, -2, and -3). In addition, IL-1 and TNF-a recruit and activate CD4+ T-lymphocytes, which produce granulocyte-macrophage colony-stimulating factor (GM-CSF), interferon gamma (INF-c) and tumour necrosis factor beta (TNF-b). These cytokines amplify KC activation and promote neutrophil recruitment and adherence into the liver sinusoids [1, 22, 23] .
Hepatocytes Glycogen
Glu-1-P Fig. 1 . Hepatocyte phenotype deregulations due to ischemia and reperfusion injury. A summary of the molecular mechanisms affecting the hepatocyte is given, the specific modifications due to I/R are indicated in red. AC, adenine cyclase; AMPK, 5 0 adenosine monophosphate-activated kinase; ADP, adenine diphosphate; ATP, adenine triphosphate; A2aR, A2A adenosine receptor; Ang, angiotensin; cAMP, 3 0 -5 0 -cyclic adenosine monophosphate; ER, endoplasmic reticulum; FBPase-1, fructose 1,6bisphosphatase; GK, glucokinase; GSH, gluthatione; HO-1, heme oxygenase-1; HSPs, heat shock proteins; MAPK, mitogen-activated protein kinase; NO, nitric oxide; Nrf2, nuclear factor (erythroid-derived 2)-like 2; O 2 À , superoxide; OAA, oxaloacetic acid; ONOO À , peroxynitrite; PEP, phosphoenolpyruvate; PFK, phosphofructokinase; PK, protein kinase; RBP4, retinol-binding protein 4; SOD, superoxide dismutase; UPR, unfolded protein response; X/XOD, xanthine/xanthine oxidase.
Platelets also play an important role in hepatic I/R injury. In fact, in response to I/R, platelets synthesize and release several factors that intervene in liver transplant and hepatic regeneration [24] . These include platelet activating factor, cytokines, growth factors including NO, TGF-b, serotonin, and calpain. Platelet activating factor, which can also be produced by KC and LSEC, primes neutrophils for ROS generation and leukotriene B 4 release, further contributing to the amplification of the neutrophil response [3] . Platelets also adhere to the hepatic sinusoids and induce programmed LSEC death through the production of NO, which ultimately will result in the potent toxicant peroxynitrite (Fig. 2) [1, 25] .
Controversial mechanisms of liver cells deregulation in hepatic I/R injury
Although most of published data converge on the currently known molecular mechanisms underlying liver cells deregulation during I/R injury, other findings are not completely understood or validated up to now. The following data summarizes some of these controversies, and may provide a better understanding of why hepatic I/R injury still remains an unresolved problem in clinical practice.
Sinusoidal endothelial cells
Although LSEC injury due to I/R was reported in the late 1980s [9] , this cell type has somehow been relegated to a secondary place and only few research groups have devoted their efforts to better understand the pathophysiology of LSEC during I/R. Rauen and colleagues did demonstrate that LSEC under cold ischemia and warm reperfusion conditions exhibit markedly increased levels of ROS that ultimately lead to decrease in LSEC viability [26] . Other studies demonstrated upregulation of adhesion molecules [27] , actin disassembly and cell deregulation due to an increment in calcium-derived calpain activity [28] , and LSEC death due to elastase-mediated paracrine interactions with leucocytes [29] . Nevertheless, scarce reports investigated the physiological consequences of SEC deregulation on hepatic I/R injury, and more importantly, very little is currently known about the relative importance of LSEC de-regulation due to I/R on the global reduction in organ viability and function post-transplantation. In fact, very recent data obtained in experimental models of liver preservation for transplantation demonstrated that cold storage per se negatively affects the LSEC phenotype, becoming pro-inflammatory, pro-thrombotic, and vasoconstrictor, which is translated into acute endothelial dysfunction development [14] . Importantly, the alterations in LSEC phenotype occur due to the abolition of the blood-derived biomechanical stimuli, which have been demonstrated to be protective, and suggest that part of the beneficial effects of the normothermic machine perfusion may derive from the continuous vascular stimulation obtained with this novel and promising strategy [30] [31] [32] .
Kupffer cells
It has been shown that KC, isolated after in vivo I/R, spontaneously release increased amounts of TNF-a compared to controls, thus proposing them as main generators of this pro-inflammatory cytokine during liver I/R [33] . However, other studies have contradicted this hypothesis demonstrating that inactivation of KC with gadolinium chloride before rat liver transplantation does not reduce expression of TNF-a, then suggesting that KC are not the only source of TNF-a in the liver [34] . Of note, the stimulatory state of KC after I/R depends on the duration of ischemia, and may also differ between ischemia at 4°C and that at 37°C, and between liver grafts types, which altogether probably leads to different mechanisms of liver damage [23] .
Neutrophil accumulation
As described above, activation of neutrophils has been implicated in the hepatic microvascular dysfunction and parenchymal damage associated with I/R [35] . Still, a controversial topic is the question of how neutrophils actually accumulate within the liver. The classical theory argues that the increased expression of adhesion molecules, such as ICAM-1 and P-selectin, plays a key role in neutrophil collection and the subsequent liver damage associated with I/R [35] . By contrast, it has also been reported that neutrophil accumulation in the liver after I/R occurs independently of the upregulation of either ICAM-1 or P-selectin [36] . This alternative theory proposed that mechanical factors such as active vasoconstriction, vascular cell swelling and injury, and reduced membrane flexibility after activation of neutrophils are involved in trapping these leukocytes into the sinusoids [37] . Indeed, the extensive vascular injury happening during reperfusion partly eliminates the LSEC barrier, thus the neutrophils have direct access to hepatocytes [3] . According to this alternative hypothesis, anti-ICAM-1 therapies failed to protect liver grafts against I/R injury [38] .
Regarding the possible role of P-selectin in neutrophil recruitment, although LSEC neither contain Weibel Palade bodies nor transcriptionally upregulate relevant levels of P-selectin after liver injury [39] , a variety of interventions directed against selectins in the experimental scenario of liver I/R injury reduced hepatic neutrophil accumulation and hepatocellular injury [40] . Since these findings cannot be explained by the prevention of P-selectin-dependent rolling over the hepatic sinusoids, it has been suggested that most models of liver I/R may include some degree of intestinal ischemia, which would lead to neutrophil accumulation in remote organs including the liver [23, 41] . Thus, the lower amount of neutrophils in the liver when selectins are blocked may be a secondary effect derived from the protection of anti-selectin therapy against intestinal reperfusion injury [41] .
Time-dependent sensitivity of hepatocyte and LSEC to ischemia
Two of the liver cell types mostly affected during I/R injury are hepatocytes and sinusoidal endothelial cells, however, they show differential sensitivity to different types of ischemia: hepatocytes are more sensitive to warm ischemia, and LSEC to cold ischemia [17, 42] . In fact, although most hepatocytes remain viable for 48 h after cold preservation and warm reperfusion, LSEC rapidly suffer from severe damage (up to 50% of them end up as non-viable cells) [43] . The severity of hepatocyte damage depends on the length of warm ischemia. Short periods of ischemia (60 min) result in reversible cell injury in which liver oxygen consumption returns to normal levels when oxygen is resupplied during reperfusion. Nevertheless, reperfusion after more prolonged periods of warm ischemia (120-180 min) results in irreversible cell damage, being 90 min of warm ischemia the estimated time limit for hepatocytes survival [44] . In cold ischemia, in vitro studies demonstrated maintenance of hepatocyte function and viability up to 72 h of preservation [45] , however, experimental models of liver transplantation indicate that 24 h, or even shorter periods, of cold ischemia may be accompanied by the development of graft primary non-function after transplantation [46] . The divergence between in vitro and in vivo studies is attributed to the significant sinusoidal damage occurring during cold storage, which will result in microcirculatory abnormalities and hepatocyte injury. In fact, in vitro experiments demonstrated that LSEC function and viability are significantly compromised after 8-16 h of cold storage, and completely blunted afterwards [47, 48] . Moreover, studies using experimental models of liver preservation for transplantation showed acute endothelial dysfunction development after 16 h of cold storage, associated with significant hepatocellular injury and death [14] . Considering the intimate cellular crosstalk between LSEC and hepatocytes, it is very possible that LSEC injury due to cold storage may negatively affect hepatocyte viability, and vice versa. In fact, hepatocytes from cold stored livers exhibit perturbations in key hepatocellular functions like solute transport or drug metabolism, together with low levels of adenine nucleotides that may trigger proteolytic events, altogether contributing to liver graft dysfunction [49] . These observations indicate that aside from reducing LSEC damage, I/R injury therapy may also benefit from strategies aimed at maintaining appropriate hepatocyte functions [49, 50] .
Another factor affecting the time-dependent sensitivity of liver cells to I/R is the percentage of ischemia applied. The extent of hepatic injury, as well as part of the underlying mechanisms, depends on whether a total or partial hepatic ischemia is conducted [51, 52] . Different authors have suggested that this fact could be explained by the ''stealing phenomenon'': In contrast to what happens in the 100% hepatic ischemia, during ischemia of the left and median lobes (70% of ischemia), the hepatic flow is totally shunted through the right lobes, and even after the release of the occlusion, a significant amount of flow is still deflected (''steeled'') through the right lobes, until vascular resistance of the post-ischemic lobes decreases. This is due to the physical fact that blood will flow through the vascular path with less resistance. Thus, the recovery of blood flow and hepatic perfusion in the post-ischemic lobes occurs much later in the case of partial than total hepatic ischemia [53] . In line with these observations, the benefits of some drugs such as ATP-MgCl 2 depend on the extent of the hepatic ischemia used.
Type of cell death occurring in hepatocytes and LSEC subjected to ischemia
The exact mechanism of cell death in hepatic I/R injury remains unclear. Apoptosis of hepatic cells, including hepatocytes and LSEC, due to I/R has been described by different reports [54, 55] , and partly occurs through the c-Jun N-terminal kinase 2-mediated mitochondrial permeability transition pathway that ultimately leads to cytochrome C release and caspase activation [56, 57] . On the other hand, other groups oppose the view that the majority of cells undergo apoptosis in response to either warm or cold I/R injury, believing that necrosis is the main form of cell death [58] . This last hypothesis derives from the idea that the proportion of cells undergoing apoptosis described in other studies is not of significant magnitude, and that the degree of caspase activation does not correlate with the number of LSEC and hepatocytes supposedly undergoing apoptosis. Thus, a controversy has emerged over the past years as to whether necrotic or apoptotic cell death accounts for the severe parenchymal injury observed during hepatic reperfusion. Remarkably, and although it has been assumed that necrosis and apoptosis are different processes, a new term ''necrapoptosis'' has been coined to describe a process that begins with a common death signal and culminates in either cell lysis (necrotic cell death) or programmed cellular resorption (apoptosis), depending on factors such as the decline of cellular ATP levels [59] .
Relevance of the type of liver undergoing I/R
A variety of subclinical factors including starvation, donor age, and graft steatosis contribute to enhance liver susceptibility to I/R injury, thus increasing patient risks. It is well-known that the shortage of organs has led care centres to expand their criteria for the acceptance of graft donors. Some of these criteria include the use of organs from elderly donors and steatotic liver grafts [60] [61] [62] . However, donor age higher than 70 years, as well as use of grafts with moderate steatosis, is associated with lower patient and graft survival [63, 64] . Moreover, hepatic steatosis is the current major cause of graft rejection for liver transplantation, exacerbating organ shortage problem [1, 23, 58] . Therefore, minimizing the adverse effects of I/R injury especially in grafts from extended-criteria donors would increase the number of both suitable grafts and patients who successfully recover from a liver transplant. The first step towards achieving this objective is a full understanding of the mechanisms involved in I/R injury in these suboptimal organs.
Starvation
In clinical liver transplant, starvation of the donor due to prolonged intensive care unit hospitalization or to the lack of adequate nutritional support increases the incidence of hepatocellular injury and primary non-function [65] . The pre-existent nutritional status is a major determinant of hepatocyte injury associated with I/R. Based on the nutritional status, several experimental and clinical studies support the hypothesis that the availability of glycolytic substrates is important for maintenance of hepatic ATP levels during ischemia and for a functional recovery during reperfusion [37, 66] . Fasting exacerbates I/R injury because the low pool of glycogen results in more rapid ATP depletion during ischemia [66] . In addition, fasting causes alterations in tissue antioxidant defences, accelerates the conversion of xanthine dehydrogenase to xanthine oxidase during hypoxia, and induces mitochondrial alterations [65] . Considering these observations, an artificial nutritional support may represent a new approach for the prevention of reperfusion injury in fasted patients [67] . However, fasting has been reported to improve organ viability and survival when long periods of ischemia are applied, as it reduces KC phagocytosis and the generation of TNF-a [68] . To understand these apparently contradictory results, it is important to consider the different experimental conditions of those investigations. A beneficial effect of high glycogen content is mainly expected under conditions of short ischemia, when high metabolic reserves within the liver may attenuate ischemic cell injury and preserve defence functions against cytotoxic mediators of KC. Conversely, long ischemic periods may preferentially demand lower metabolic reserves since KC become de-activated and will not contribute to early graft injury.
Age
Under warm hepatic ischemia, mature adult mice show markedly increased neutrophil activity and intracellular ROS, and decreased mitochondrial function compared with young adult mice. Mature adult mice have much lower hepatic expression of the cytoprotective heat shock protein 70 (HSP70) than young adult mice. In contrast, serum HSP70 levels, which have been linked to subsequent tissue injury, are higher in mature than in young adult mice [69] . These alterations may contribute to the exacerbated liver injury after I/R observed in elderly mice compared with young animals. On the other hand, using the experimental model of the isolated perfused liver, previous studies demonstrated lower production of oxyradicals in old animals compared to livers from young rats. This fact was explained by lower KC activity, reduction in liver blood flow, and the impaired functions and structural alterations observed in the livers of old rats [70] . In hepatocytes from mature adult mice, delayed activation of nuclear factor kappa B (NFjB) in response to TNF-a and virtually no production of macrophage inflammatory protein 2 have been detected [69] . Evidently, further investigations are required to better understand the pathophysiological status of liver grafts from old donors.
Steatosis
The first step to minimize the adverse effects of I/R in steatotic livers is a full understanding of the mechanisms involved in I/R injury in these marginal organs. Microcirculatory dysfunction probably represents the main underlying mechanism of steatotic liver I/R injury [67, 71, 72] , nevertheless, other hypotheses have also been suggested. Hepatocyte damage is remarkably higher in steatotic livers than in non-steatotic livers [73] , and may contribute to their poor tolerance to I/R. Hepatocyte de-regulation has several causes, it may be partially explained due to an increased sensitivity to ROS that will affect mitochondrial processes including those responsible for ATP synthesis. In fact, steatotic livers synthesise less ATP than non-steatotic livers during 
Rat
Warm ischemia 60 min ↓ Hepatic injury, inflammation and oxidative stress post-ischemic reperfusion [7, 74] , being the upregulation of the mitochondrial uncoupling protein 2 a key underlying mechanism [75] . In addition, it has been described that hepatocytes with fatty infiltration develop massive necrosis after I/R injury, instead of apoptosis observed in non-steatotic livers [61] . This fact may be due to low ATP production and dysfunction of regulators of apoptosis (Bcl-2, Bcl-xL, and Bax), and may explain why caspase inhibition, a highly protective strategy in non-steatotic livers, had no effects on hepatocyte injury in steatotic livers [73] . In experimental models of liver transplantation, exogenous NO adminis-tration protected non-steatotic grafts but was ineffective, or even noxious, in livers with steatosis. The injurious effects of exogenous NO donors was explained by exaggerated peroxynitrite generation caused by ROS overproduction [76] . Heme Table 2 . Additives for preservation solutions to protect livers against ischemia/reperfusion injury. 
Additives for preservation solution
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Cold ischemia 2 h ↓ Endoplasmic reticulum stress APC, activated protein C; BAX, Bcl-2-associated X protein; Bcl-2, B-cell lymphoma 2; EGF, epidermal growth factor; HO-1, heme oxygenase-1; IGF-1, insulin-like growth factor 1; IL-6, interleukin-6; MMP, metalloproteinase; NO, nitric oxide; PAF, platelet activating factor; LSEC, liver sinusoidal endothelial cells; TNFa, tumor necrosis factor a. Table 3 . Gene therapy strategies aimed at protecting liver grafts against ischemia/reperfusion injury. oxygenase-1 (HO-1) activators such as cobalt (III) protoporphyrin IX might protect livers against warm I/R injury. However, a much lower dose of the HO-1 activator is required to protect steatotic livers, as they show higher HO-1 basal levels than non-steatotic livers [77] . Steatotic livers also differed from non-steatotic grafts in their response to the unfolded protein response and endoplasmic reticulum stress, indeed the expression of inositol-requiring enzyme 1 and PKR-like endoplasmic reticulum kinase is lower in the presence of steatosis [78] . Differences have also been observed analyzing the role of the renin-angiotensin system, non-steatotic grafts exhibited higher angiotensin (Ang)-II and lower Ang-(1-7) levels than steatotic grafts [79] . Moreover, reduced retinol binding protein 4 and increased peroxisome proliferator-activated receptor gamma (PPAR-c) levels were observed in steatotic livers compared to non-steatotic livers [80] . The increased vulnerability of steatotic livers subjected to I/R has been also associated with increased adiponectin, oxidative stress and IL-1 levels, and reduced capability to generate IL-10, PPAR-a and Retinol-Binding Protein 4 [80] [81] [82] . Very importantly, it should be considered that the mechanisms involved in hepatic I/R injury may differ depending on the method used to induce experimental steatosis. In contrast with other models of steatosis, both dietary and alcohol exposure induces the production of superoxide dismutase/catalase-insensitive ROS, which may partly justify steatotic liver failure after transplantation [83] . Neutrophils, which have been involved in the increased vulnerability of alcohol-induced steatotic livers to I/R injury, would not account in I/R damage in non-alcoholic steatotic livers. Similarly, the role of TNF-a in the vulnerability of stea-totic livers to I/R injury may depend on the type of steatosis [23, 84] . All the aforementioned observations indicate that therapies that are effective in non-steatotic livers may either be useless in the presence of steatosis, or the effective drug dose may differ between types of grafts [1, 76, 77] . On the other hand, some pharmacological compounds would only be effective in steatotic livers [23, 58] . In summary, the different mechanisms involved in hepatic I/R injury depending on the type of steatosis could explain the difficulties to translate our current knowledge to the bedside.
Gene therapy
Strategies to prevent hepatic I/R injury
As a consequence of the incipient amount of uncovered molecular mechanisms responsible for hepatic I/R injury, a variety of new therapeutic strategies have been developed (Tables 1-4 ). Due to limitation in review length, only those strategies reported during the last 5 years have been included in the present review. For less recent studies please refer to previous articles [1, 23, 58, 85, 86] .
Concluding remarks and future directions
Over the past years, our knowledge about the mechanisms involved in the development of liver injury due to I/R has significantly improved, and it has consequently been accompanied by a long list of potential therapeutic alternatives. However, ischemiareperfusion injury still represents a serious problem in the clinical practice probably because very few basic (or translational) studies have successfully been applied at the bedside. This important drawback in hepatic I/R experimental research may have several origins. Firstly, and as stated along this review, it should be considered that the mechanisms involved in hepatic I/R very much depend on the experimental conditions used: which type of research is done (in vitro, ex vivo, in vivo), type of ischemia applied (warm or cold), period of ischemia (ranging from minutes to days), extension of hepatic ischemia (partial or total), graft subclinical situation (healthy, steatotic, aged. . .), etc. Thus, new therapeutic strategies from experimental studies should be considered specific to the concrete experimental/surgical conditions used, and most probably they cannot automatically be validated for a different I/R situation. Secondly, although we certainly know part of the underlying molecular mechanisms of I/R injury in hepatocytes and Kupffer cells, much fewer knowledge has been gained for other key hepatic cells such as liver sinusoidal endothelial cells or hepatic stellate cells. Thus further investigations are still required. Nevertheless, liver cells phenotype modifications due to I/R injury should be investigated in experimental conditions that maximally mimic the hepatic sinusoid environment, including the possibility of paracrine interactions and under physiological biomechanical stimuli. Third, it should be taken into consideration that the possible applicability of basic research knowledge is even more difficult in clinical situations with extended-criteria donors. The relative homogeneity of liver steatosis obtained in genetically modified animals or animals under dietary alterations cannot be compared to humans, where surgeons are still looking for a reliable method for hepatic lipid content quantification, and similarly happens with elderly donors, non-beating heart donors, etc. Overall foster complicating the applicability of basic research.
In conclusion, multidisciplinary research groups should devote additional efforts to better understand the cellular alterations and the crosstalk within the liver during I/R injury to ultimately develop effectual therapeutic strategies aimed at improving graft viability post-transplantation or resection, and at significantly increasing the organ donor pool.
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